Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
Clinical trial NCT06356597 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06356597
- Sponsor
- Jing-yuan Fang, MD, Ph. D
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2026-12-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.